New SPECT/CT technique shows impressive biomarker identification, offers increased access for prostate cancer patients
Reston, VA—A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening...
